(I) Introduction (A) BIOCHEMICAL PROPERTIES OF GROWTH FAC-TOR RECEPTORS WITH TYROSINE KINASE ACTIVITY
The biology of growth factors differs from hormones in that neither their site of production nor their site of action is restricted to definite tissues. Many of these factors elicit their actions by binding to and activating the cell surface receptors with an intrinsic protein tyrosine kinase activity. All receptor tyrosine kinases have similar molecular structures. They possess three major domains: an extracellular domain, a single hydrophobic membrane spanning domain, and a cytoplasmic domain (Ullrich and Schlessinger, 1990) . The cytoplasmic domain contains, in addition to the catalytic tyrosine kinase portion, distinct regulatory sequences which are activated by phosphorylation on tyrosine, serine, and threonine residues (Carpenter, 1987; Kovacina et al, 1990) . The tyrosine kinase activity of the receptor is essential for inducing the signal transduction pathway leading to mitosis, transformation, and cell differentiation. While the major activity of receptor tyrosine kinase is to stimulate cell growth and proliferation, some tyrosine kinases arrest growth and promote differentiation. The stimulatory or inhibitory nature is determined by properties of the receptor tyrosine kinase and the cell environment.
Growth factors are small proteins that directly regulate cell growth and differentiation. These peptides may act on the producing cell (autocrine stimulation), on adjacent cells (paracrine), or distant cells (endocrine) (MacKay et al, 1992) . One of the first growth factors to be discovered and biochemically characterized was epidermal growth factor (EGF), a product of the ductal cells of the submandibular gland . All members of the EGF family of growth factors (i.e., EGF, TGFoc, and amphiregulin) contain a similar core structure and bind to a common receptor located on the surfaces of target cells.
The active 53-amino-acid mature form of EGF is generated by the proteolytic processing of a 1207-aminoacid membrane-associated precursor (Fisher and Lakshmanan, 1990) . EGF is a potent cell mitogen (Cohen, 1962) which has been found in virtually every fluid, including blood, urine, sweat, tears, prostatic fluids, gastrointestinal secretions, and saliva (Fisher and Lakshmanan, 1990) . It has been suggested that one of the major biological roles of EGF is to renew and maintain the epithelial tissues of the body. It is not inconceivable, then, that overexpression of EGF or TGFa in cells in culture leads to malignant transformation (Stern etal, 1987) .
All growth factor receptors undergo dimerization following ligand binding (Gladhaug and Christoffersen, 1987) . This dimerization activates the intrinsic tyrosine kinase of the receptor. Available evidence indicates that growth factor receptor kinases phosphorylate several intracellular proteins, including oncogenes, tumor suppressors, and cytoskeletal proteins. Addition of growth factors, particularly EGF and platelet-derived growth factor (PDGF), has been shown to induce tyrosine phosphorylation of phospholipase Cy (PLCy) both in vivo and in vitro (Margolis et al, 1989; Wahl et al, 1990) . Reports from 6(2): 119-131 (1995) Crit Rev Oral Biol Med various other laboratories provide evidence that PI 3-kinase and p2\ ms GTPase activating protein (GAP) are also substrates for growth factor receptor tyrosine kinases (Ullrich and Schlessinger, 1990) . The stimulation of PLCy results in generation of two important second messengers-inositol trisphosphate and diacylglycerol-which cause the mobilization of Ca 2+ from intracellular sources and activation of protein kinase C, respectively (Berridge, 1987) . Binding of growth factors to their specific receptors not only phosphorylates proteins on the tyrosine residues but also stimulates phosphorylation of substrates on serine and threonine residues. The substrates phosphorylated on serine and threonine residues include protein kinase C F ribosomal S6 kinase, mitogenactivated protein (MAP) kinase, and Raf A kinase (Bowen et al, 1991) . Thus, the common targets that have been identified are components of second-messenger signaling pathways which can form oncogenic products when overexpressed or mutated in tissue culture cells. One target of activated protein kinase C is the serine phosphorylation of the EGF-R, which brings about the down-regulation of intrinsic tyrosine kinase activity of the receptor (Li et al, 1994) . Subsequent to autophosphorylation of the EGF-R or the insulin receptor, they are either degraded or recycled to the cell surface. Studies using EGF or insulin receptor mutants indicate that the kinase activity is necessary for the ligand-induced down-regulation (Bowen etal, 1991; White and Kahn, 1994) .
The association between tyrosine phosphorylated regions in growth factor receptors and the signaling proteins is mediated by a conserved region of approximately 100 amino acids, termed Src homology-2 (SH2) domains. Numerous SH2-containing proteins have been identified which play a significant role in propagating the cytoplasmic signals following activation of receptor tyrosine kinases. Based on their primary structure, these proteins can be divided into two main classes. Type I class proteins contain, in addition to the SH2 domain, catalytic activities such as those described for PLCy, pp60
Src , and the Ras-guanine nucleotide exchange factor (SOS) (Pawson and Gish, 1992) . SH2 domains of this class of molecules directly mediate their interaction with tyrosine-phosphorylated receptor and other tyrosine-phosphorylated proteins.
The type II class of SH2-containing proteins includes: c<rk, nek, and GRB2/Sem-5 (Lehman et al, 1990; Lowenstein et al, 1992) . These proteins contain only SH2 and SH3 domains. These proteins are thought to function as regulatory components or adapters for specific catalytic proteins of the type I class. For example, in the case of PI 3-kinase, p85 has been shown to be a regulatory subunit of pi 10 which functions as the catalytic subunit of PI 3-kinase (Carpenter and Cohen, 1990; McGlade et al, 1992) . Another example of type II SH2-containing proteins is GRB2, which is a human homologue of Sem~5, a Caenorhabditis elegans signal transduction protein. Clark et al (1992) have shown that GRB2 may be involved in the control of growth-factor-induced Ras signaling by stimulating the activity of SOS or possibly by inhibiting a Ras GTPase activity.
In this review, we will explore the relationship of salivary gland proliferation with the activation of the EGF-R signal transduction pathway. Where we understand the mechanism, we will attempt to correlate second-messenger "pathway cross-talk" and the regulation of secretory function by tyrosine kinases and phosphatases. In the course of this review, our limited understanding of some of these events will become obvious. However, as new tools become available, we hope that our knowledge of salivary gland function in the presence of activated tyrosine kinase signaling becomes more clear. Such an understanding will be necessary if we are to contemplate the possibilities of restoring differentiated cells and function to a gland destroyed by disease.
(B) SIGNAL TRANSDUCTION FROM

PLASMA MEMBRANE TO NUCLEUS
In a multicellular organism, cells communicate with one another in order to regulate various activities, including growth, development, and organization into tissues. Various signaling molecules bind to specific cell surface receptors to relay extracellular signals inside the cell. Thus, the cell surface receptors exert their influence on the cytosol or nucleus by production of new intracellular signals and, ultimately, trigger changes in gene expression. Ras proteins have been implicated as playing a major role in mediating the signal upstream tyrosine kinase to downstream serine and threonine kinases, which then would activate several transcription factors in the nucleus (Khosravi-Far and Der, 1994) . In addition to p2\ ms protein, a set of molecules appears to be activated by the receptor tyrosine kinase. These molecules include mitogen-activated protein kinases (MAP-kinase), extracellular signal-regulated kinase (ERKS), MAPkinase/ERK-activating kinase (also referred to as MEK), Raf protein kinase, guanine nucleotide-releasing factors, Src homology-containing adapters, and protein phosphatases (for review, see White and Kahn, 1994) . Even though the biochemical details of the above cascade of events are still not clear, the role of protein phosphorylation by Raf, MEK, and MAP kinases in regulating various steps has been documented in many cell systems (Leevers and Marshall, 1992; Cook and McCormick, 1993) . Recent evidence indicates that MAP-kinase translocates from the cytoplasm to the nucleus upon growth factor stimulation. These observations demonstrate the importance of MAP-kinase in the regulation of transcription factor activity (King et al, 1994; Nurse, 1994) . Overexpression of p44 erk 1 (MAP-kinase) has been shown to stimulate transcription of activator protein 1 (API) and to activate, directly or indirectly, several cellular proto-oncogene products, namely, c-myc, c-fos, and cjun (Baker et al, 1992; Seth et al, 1992; Pages et al, 1993) . A 90-kDa ribosomal S6 kinase {pp90 rsk ) that is phosphorylated and activated by MAP-kinase has been localized to both the cytoplasm and the nucleus (Chen et al, 1993) . It is apparent that tyrosine-mediated regulation of cell growth and differentiation is transduced through the Ras protein and several serine and threonine kinases which traverse the nuclear membrane to bring about activation of protein machinery specifically involved in DNA synthesis and cell division.
A thorough understanding of these pathways may have significance in cancer diagnosis and treatment. In this regard, tumors of the salivary gland are just as likely to reflect changes in the phosphotyrosine signaling pathway. It might also provide input into drug design to antagonize the Ras pathway. The identification of SH2 and SH3 domains with the ability to facilitate protein-protein interactions may prove useful in designing synthetic compounds that mimic inhibitors of the Ras pathway.
(II) Adnar Cell Proliferation (A) PARALLELS IN ISOPROTERENOL AND EGF-STIMULATED CELL GROWTH
This year celebrates the 34th anniversary of the first reports on the use of the P-adrenergic agonist, isoproterenol, to induce salivary gland hypertrophy and hyperplasia (Brown-Grant, 1961; Selye et al, 1961) . Over the intervening years, substantial progress has been made not only in our understanding of the mechanism by which P-adrenergic receptor activation leads to cell growth but also in the whole field of cell biology, which has begun to unravel the mysteries governing the steps and regulation of cell proliferation. With the use of proto-oncogenes (homologs of normal cellular proteins), the general outline of the pathways leading to growth has been elucidated (Crews and Erikson, 1993) . The initiating event in mature, differentiated cells requires an extracellular signal, typically supplied by a receptor ligand. The binding of ligand to the external surface of the cell introduces a response cascade on the inner surface of the plasma membrane. The intracellular communications and cellular responses are typically governed by the balance of protein phosphorylations and dephosphorylations.
There is also strong evidence that overexpression of the EGF receptor (EGF-R), especially mutated forms, can lead to transformation. The v-erb B oncogene appears to be a truncated version of the EGF-R that lacks an extracellular domain and contains a constitutively active tyrosine kinase domain (Yamamoto et al, 1983) . Many human tumor cell lines overexpress the EGF-R by 10-to 100-fold compared with normal cells (MacKay et al, 1992) . The activation of the receptor sets up a series of phosphorylation reactions dependent upon the amino acid tyrosine. The protein components of this pathway pass into the nucleus, causing the cell to undergo DNA synthesis and cell division by the activation of transcription factors and the cell cycle machinery (Hunter and Pines, 1994; Kingetal, 1994; Nurse, 1994) .
Chronic administration of isoproterenol has a dramatic growth-stimulating effect on the salivary glands of rats and mice (Schneyer, 1962; Barka, 1965) . Specifically, it induces hypertrophic and hyperplastic enlargement of parotid and submandibular glands. Parotid gland enlargement can also be obtained by dietary changes as well as by administration of growth hormones such as EGF (Humphreys-Beher et al, 1990) .
The responses to extracellular signals are generally initiated by their binding to cell surface receptors. This "receptor-ligand" type of interaction generates second messengers intracellularly which ultimately cause cell proliferation. In the case of EGF, it has been shown that activation of the pathway leading to DNA synthesis and cell division results from interaction with the EGF-R. This interaction stimulates the phosphorylation cascade and activation of intracellular second messenger proteins that eventually activate transcription factor and cell cycle machinery required for mitosis (Hunter and Pines, 1994) . The activation of the tyrosine kinase signaling pathway additionally results in second messenger pathway crosstalk in acinar cells. Of particular interest, due to their involvement in the regulation of acinar cell secretion, is the activation of protein kinase C and cAMP-dependent protein kinase A as well as the increases in intracellular free Ca 2+ . Protein kinase A activation takes place in a padrenergic receptor-independent fashion involving G protein intermediates (Nakagawa et al, 1991) . The growth-stimulating aspect of chronic isoproterenol treatment on the parotid gland has been somewhat of an enigma in light of the fact that this compound is a Padrenergic receptor agonist (Quissell et al, 1992) . As such, the injection of isoproterenol has served as a model system for the elucidation of salivary gland secretory function. However, it has been the growth-promoting aspect that has received attention over the last several years. To this end, it has now been established that parotid acinar cell mitosis can be promoted by the localization of P1-4 galactosyltransferase to the plasma membrane of isoproterenol-treated animals (HumphreysBeher et al, 1990; Purushotham et al, 1992) . The transition of acinar cells from quiescent to active proliferation is accompanied by an increased expression and localization of the galactosyltransferase to the plasma membrane (Humphreys-Beher et al, 1987; Marchase et al, 1988; Humphreys-Beher, 1989) . The participation of galactosyltransferase in regulating growth was confirmed by the introduction of the glycoprotein ovalbumin, a galactosyl-transferase substrate, a substrate modifier protein oc-lactalbumin, or antibody to galactosyltransferase at the time of isoproterenol or hormone treatment-all of which resulted in a decrease in cell hypertrophy and hyperplasia (Humphreys-Beher et al, 1987) . Of the glycosyltransferases, pi-4 galactosyltransferase is primarily localized within Golgi apparatus, transferring the galactose in a (31,4 anomeric configuration to N-acetylglucosamine residues of glycoconjugates from the nucleotide sugar UDP-galactose (Kornfeld and Kornfeld, 1985) . A portion of the enzyme has been localized to the plasma membrane in various cells (Penno et al, 1989; Podolsky et al, 1978) . Cell surface galactosyltransferase has been shown to mediate several biological phenomena, including cell-cell and cellmatrix interactions (for review, see Cooke and Shur, 1994) . It has also been implicated in the regulation of growth, since abnormal expression leads to uncontrolled growth in transformed cells. Recent evidence suggests that both isoproterenol and EGF-induced proliferation of parotid gland acinar cells involve the activation of intrinsic tyrosine kinase activity of the EGF-R . This activation is consistent with autophosphorylation of tyrosine on the EGF-R and translocation of cytosolic PLCy to the plasma membrane. The isolation and characterization of EGF-R from isoproterenol-treated parotid gland membranes revealed alterations in lectin binding and a capacity to interact with endogenous or exogenous galactosyltransferase . These altered carbohydrate moieties of the receptor appear to initiate the second messenger signaling pathway, as has been observed in response to EGF, by inducing a conformational change in the receptor which leads to its activation .
With the observation of stimulating EGF-R tyrosine kinase activity in parotid a&nar cells, following interaction with galactosyltransferase, we have elaborated on the subsequent pathways in isoproterenol-treated acinar cells to show parallels with EGF stimulation (Nakagawa etal, 1991 (Nakagawa etal, , 1992 Purushotham et al, 1993 Purushotham et al, , 1994a Wang et al, 1993) . Salivary glands are no exception in generating multiple responses as a consequence of signal transduction 'cross-talk'. Several proteins become associated with the activated receptor through the presence of SH2 domains. In parotid acinar cells, these proteins include p2\ ras , GAP, SOS, PI 3-kinase, and PLCy. Other kinases of phosphatidylinositol metabolism, such as PI 4-kinase, are also activated by EGF-R in acinar cells (Purushotham et al, 1993) . The phosphorylation of SOS and GAP in parotid cells regulates the downstream activity of p2\ ms (Nakagawa et al, 1991; Wang et al, 1993) . Parotid gland cells differ in temporal regulation and membrane association of the Ras exchange factors SOS and GAP, due to the self-limiting non-neoplastic growth of EGF and isoproterenol-stimulated proliferation not seen in studies with transformed cells (Fantl et al, 1993) . During initial phases of proliferation (3-4 days), SOS is associated with plasma membrane EGF-R (Wang et al, 1993) . It is only when hyperplasia declines (5-6 days) that GAP appears to be activated at the plasma membrane (Nakagawa et al, 1992) . Son of sevenless is a positive modifier of p2\ ms activity through increases in the level of GTP bound to the protein, while GAP returns p2\ ms to the down-regulated state by hydrolyzing p2\ ras bound GTP to GDP. The signals initiated by p2\ ms GTP are further enhanced by several events leading to activation of the serine and threonine kinases Ra/-1 and MAP-kinase . Here again, both isoproterenol-and EGF-stimulated acinar cell growth involve activation of these kinases, which ultimately leads to cell division through activation of transcription factors such as Rb 110 , myc, fos, and jun (Kousvelari et al, 1988 (Kousvelari et al, , 1990 Mirels et al, 1989; Kawano et al, 1992; Lee et al, 1992; Pulverer et al, 1993) . Inoue and co-workers (Kawano et al, 1992) have additionally shown isoproterenol treatment to cause increased mRNA and protein levels for ornithine decarboxylase (an enzyme required for DNA synthesis) and the sre proto-oncogene.
Cell proliferation is also controlled by protein tyrosine phosphatase, which down-regulates the signals generated by tyrosine kinases. In parotid acinar cells, this is facilitated by the activation of Syp (an SH2 domain containing protein tyrosine phosphatase) in response to either isoproterenol or EGF stimulation . Total cell lysates from stimulated parotid glands have been immunoprecipitated with antibody to Syp and used in dephosphorylation reactions with [ 32 P)-labeled myelin basic protein (MBP) as the substrate. Isoproterenol and EGF treatment increased dephosphorylation of MBP, while the level of p65 Syp remained unchanged between unstimulated and stimulated parotid glands (Purushotham et al, , 1995b . Syp protein itself is a substrate for both tyrosine and threonine phosphorylation in activated cells (Purushotham et al, , 1995b . Thus, unlike the activation of phosphotyrosine signaling kinases, which undergo both increased synthesis and activation in response to growth stimuli, Syp concentration in the cell remains constant, and its activity is increased by direct phosphorylation (unpublished results).
Cyclic AMP has been shown to stimulate cell growth in some tissues (PC 12 cells, parotid and submandibular gland acinar cells) while inhibiting growth in others (fibroblasts, fat cells, smooth muscle cells) (Hafner et al, 1994; Hordijk et al, 1994) . The exact molecular mechanism detailing such contrasting effects of cAMP has been the subject of study by several investigators in the last two years (Cook and McCormick, 1993; Hafner etal, 1994; Hordijk et al, 1994) . The new findings on cAMP interference with Ra/-1 -MAP-kinase, through evidence suggesting that protein kinase A mediates phosphorylation of Raf~1, leading to a blockade in the p21 ras pathway (Hordijk et al., 1994) , may partly explain the above paradoxical effects of cAM P. The role of cAMP in inhibiting the proliferative responses by EGF and isoproterenol in salivary glands has been evaluated by examining the ability of immunoprecipitated MAP-kinase to phosphorylate myelin basic protein . Cyclic AMP levels in parotid acinar cells were elevated by adenylate cyclase activation following treatment of cells with isoproterenol, direct stimulation of adenylate cyclase by forskolin, or by preventing cAMP degradation by the phosphodiesterase inhibitor, 3-isobutyl-l-methylxanthine. The level of MAP-kinase was three-fold higher in cells treated with EGF than in controls. Pre-treatment with isoproterenol did not lower the kinase activity as might be expected from the above studies using Rat-\ cells in culture (Cook and McCormick, 1993) . For verification of the activation of MAP-kinase in the presence of cAMP, immunoprecipitated MAP-kinase was separated by SDS-polyacrylamide gel electrophoresis and evaluated for slower migration of p44 and p42 due to EGF-stimulated phosphorylation. Under the three conditions of cAMP accumulation, EGF was able to phosphorylate MAP-kinase to the same degree as control cells treated with EGF alone. The association of protein kinase A with the Raf~\ -MAP-kinase complex increased in response to cAMP; however, there was no subsequent inhibitory effect on signal transduction. One possibility for the continued Ra/-1 -MAP-kinase activity in the presence of "inhibitory" cAMP levels might be due to the association of other factors in this complex, such as protein kinase C or a G-protein intermediate (G sct ), which could influence serine and threonine phosphorylation levels of other protein kinases in this complex.
The localization of MAP-kinase in both cytoplasm and nucleus of acinar cells provides a physical link in the signal transduction pathway from the cell surface to the nucleus. MAP-kinase has been shown to be involved in activation of cyclin B/cdc2 complex during mitosis (King et al, 1994; Nurse, 1994) and transcription factors such as Myc, }un, Fos, and Rb 110 . The identification of these proliferation-associated transcription factors following isoproterenol treatment of acinar cells provides a link between MAP-kinase and activation of phosphotyrosine pathway leading to cell division.
(HI) Examples of Induced Proliferation of Acinar Cells (A) GROWTH FACTORS
Growth factors such as nerve growth factor (NGF) and epidermal growth factor (EGF) have been shown to induce specific increases in parotid gland size and cell division (Schneyer and Humphreys-Beher, 1988) . lntraperitoneal administration of EGF to rats (25 |Lig/kg twice daily for three days) resulted in a 1.5-fold increase in parotid gland size . The evidence for the increase in gland size specifically due to EGF comes from in vivo studies using antibodies to the growth factor or its cell surface receptor. Co-administration of a polyclonal antibody to EGF or EGF-R resulted in complete inhibition of the growth-promoting potential observed with EGF injection . The changes in gland size in response to EGF alone were confirmed further by measuring the [ 3 H)-thymidine incorporation. EGF responses are initiated at the cell surface by interaction of the ligand with its specific receptor. This interaction then results in activation of intrinsic tyrosine kinase activity of the receptor and subsequent phosphorylation of various cellular proteins. Increased cell division in response to chronic high doses of NGF appear to be the consequence of increased gland innervation and release of norepinephrine in the gland Humphreys-Beher, 1988, 1989) . Thus, NGF-stimulated growth is similar to that observed by chronic injection of isoproterenol.
Insulin, considered a hormone rather than a growth factor, can also influence acinar cell proliferation when the protein is chronically administered in high doses (Wang et al, 1994a,b) . The activation of the phosphotyrosine second messenger pathway by insulin involves both the insulin receptor and the intracellular tyrosine kinase activity of the insulin receptor substrate-1 (White and Kahn, 1994) . Activation of insulin receptor tyrosine kinase activity in acinar cells leads to phosphorylation of PLCy, p21 ras -GAP, and PI 3-kinase .
(B) CHRONIC ADMINISTRATION OF ISOPROTERENOL
Chronic administration of isoproterenol (25 mg/kg twice daily for 3 days, intraperitoneal injections) to rats has been shown to cause hypertrophic and hyperplastic growth of the parotid gland, determined by the measurement of gland weight and ( 3 H]-thymidine incorporation into DNA, respectively . Cell surface galactosyltransferase has been identified as playing a significant role in mediating the isoproterenolinduced responses leading to acinar cell proliferation. The transition of the cells to a growth state is accompanied by an increased expression and localization of galactosyltransferase to the plasma membrane. Elevation of surface galactosyltransferase is also observed in human parotid tumors (Humphreys-Beher et al, 1990) . The most pronounced hyperplasia is evident during the initial phase of isoproterenol treatment, but it is not neoplastic, for it results in limited enlargement of the gland that is partially reversible upon cessation of isoproterenol stimulation (Schneyer, 1969) . The levels of DNA, RNA, and protein synthesis are all increased following isoproterenol administration. The evidence to show that these responses are partly mediated by increas-
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es in cyclic nucleotide second messengers follows from utilization of p adrenergic antagonists which blocks these changes (Nair et al, 1989; Nakagawa et al, 1992) . The intracellular increases in cAMP lead to the activation of protein kinase A, phosphatidylinositol hydrolysis, and Ca 2+ mobilization, suggesting a possible v cross-talk' between the second messenger signaling systems (Tojyo et al, 1991; Nakagawa et al, 1992) . While alteration in intracellular Ca 2+ levels observed by isoproterenol treatment appears to be independent of phosphoinositide turnover, maximal secretion of amylase from parotid acini and mucin from submandibular cells occurs by a synergistic increase of both pathways (McKinney et al, 1989; Mills et al, 1993) . In pancreatic P-cells, activation of protein kinase A by cAMP leads to increased intracellular Ca 2+ pools, but a decrease in phospholipase C activation (Rasmussen et al, 1992) . Again, this observation may represent the dichotomy of the effects that cAMP has on acinar cells compared with other cell types (Cook and McCormick, 1993; Hafner et al, 1994; PurushothameUf., 1994a ).
(C) DIETARY STIMULATION OF PAROTID GLAND
PROLIFERATION
Several parallels have been established between the growth response of the parotid gland following dietary or gustatory stimulation and that observed in mitogenesis of the gland following chronic isoproterenol stimulation. Maintenance of rats exclusively on a liquid diet results in a reduction in the size of the parotid gland four days after its introduction (Hall and Schneyer, 1973; Johnson, 1983) . However, re-introduction of a solid diet restores gland size and also induces a sharp burst of mitosis that peaks at two days after the dietary change (HumphreysBeher et al, 1990) . Gland hypertrophy and hyperplasia can also be induced following replacement of a normal solid food diet with a diet containing increased nonnutritional bulk Schneyer, 1977, 1978) . These dietary changes are accompanied by increased masticatory activity and hence increased autonomically mediated glandular activity (Hall and Schneyer, 1978) . Such a response can be induced by direct electrical stimulation of the sympathetic nerve, which also induces gland hyperplasia (Schneyer etal, 1991 (Schneyer etal, , 1993a .
The importance of the P-adrenergic receptors in the mediation of this process has been described (Schneyer, 1962 (Schneyer, , 1969 Barka, 1965; Brenner and Stanton, 1970) . Thus, the increased release of agonists or injection of agonists such as isoproterenol promotes proliferation through cell surface galactosyltransferase and activation of the phosphotyrosine signaling pathway as described above. Dietary changes that induce hyperplasia are prevented by interfering with the function of cell surface transferase (Humphreys-Beher and Schneyer, 1987; Schneyer etal, 1993b) .
Less well-established, however, is the role of the parasympathetic nerve in the mediation of mitogenic responses. Removal of the parasympathetic innervation prior to dietary changes inhibits mitogenesis (Schneyer etal, 1991) . The same retardation rates in DNA synthesis and appearance of cell surface galactosyltransferase activity are obtained by injection of parasympathetic nerve antagonists (Schneyer et al, 1993b) . This suggests that this innervation pathway as well as sympathetic innervation has a regulatory role in the development of glandular hyperplasia. Recently, the agonist-dependent transformation of an in vitro cell line (NIH 3T3 fibroblasts) was accomplished by the overexpression of human muscarinic receptor mRNA (Mattingly et al, 1994) . The increase in muscarinic receptor density led to a situation in which there was chronic activation of inositol phosphate metabolism by cellular phospholipase Cs. Furthermore, the signal transduction pathway leading to growth involved activation of Ras and p21 ras -GAP. The muscarinic receptor family is composed of five subtypes encoded by distinct genes (Bonner et al, 1987) . Subtypes M p M 3 , and M 5 , which couple through heterotrimeric G proteins to activate PLC, are able to transform NIH 3T3 fibroblasts and primary cultures of glial cells in the presence of the agonist carbachol (Gutkind et al, 1991) . Using dominant negative mutations or construction of a p21 ras -GAP catalytic domain-containing plasmid, Mattingly et al. (1994) showed that activation of the Ras-dependent signaling pathway involved interaction with heterotrimeric G proteins stimulated by the muscarinic receptor.
(D) SALIVARY GLAND TUMORS
An analysis of human parotid tumors-such as squamous cell carcinoma, Warthin's tumor, and malignant pleomorphic adenocarcinoma-shows alterations in signal transduction component activation similar to proliferation induced by chronic administration of isoproterenol or EGF in animal models of salivary gland growth [Bu etal., 1995) . Higher levels of membrane expression of galactosyltransferase, receptor tyrosine kinase, and PI 3-kinase were observed. Immunohistochemical analysis of tumor preparations for the presence of c-erbB-2 (an isoform of the EGF-R) has indicated higher levels in the membranes from parotid tumors when compared with normal tissue (Bu et al, 1995) .
Cytoplasmic serine and threonine kinases have been identified as playing a significant role in the control of cell proliferation by down-regulating either the Raf-l-MAP-kinase pathway (Cook and McCormick, 1993) or tyrosine kinase activity of the EGF-R. The levels of second messenger cAMP and activity of serine and threonine kinases involved in phosphorylation of proteins, namely, protein kinase A and protein kinase C, were found to be elevated in tumor tissues relative to surrounding normal tissue. The protein kinase C activity in Warthin's tumors, squamous cell carcinoma, and malignant pleomorphic adenoma was found to be substantially greater when compared with controls. Protein kinase A activity also showed much higher activity (8-to 20-fold) in the tumors examined. The ability of the tumors to secrete amylase activity (synthesized by acinar cells) and EGF and TGFcc (synthesized by ductal cells) was measured. Amylase activity in squamous cell carcinoma was 22% of control tissue, while the activity in Warthin's tumor and malignant pleomorphic adenoma was almost undetectable (Bu et al, 1995) . The growth factors (EGF and TGFa) associated with tumors were substantially elevated compared with the controls. It is possible that these growth factors might stimulate the cells to proliferate through a self-regulatory autocrine fashion involving expression of c-erb and receptor ligands EGF and TGFa (MacKay et al, 1992) . With the high levels of growth factor present in the tumors, it may be possible that cell surface galactosyltransferase may have a secondary role in controlling tumor cell metastasis. In fact, galactosyltransferase has been shown for a number of cell types to regulate both in vivo and in vitro cell migration on laminin basement membrane components (Maillet and Shur, 1994) . The appearance of cell surface galactosyltransferase has been found to correlate with the metastatic potential of a number of human tumors (Penno et al, 1989) .
(IV) Protein Phosphorylation in Exocytosis (A) ROLE OF PHOSPHORYLATION IN SECRETION
Salivary gland exocytosis involves the activation of protein kinase A and subsequent phosphorylation of a number of proteins. Protein phosphorylation/dephosphorylation has been suggested as a possible molecular mechanism in the regulation of salivary gland exocytosis (Jahn et al, 1980; Baum et al, 1981; Spearman et al, 1984; Quissell et al, 1985; Fuller et al, 1989) . Although several proteins have been reported to undergo phosphorylation, a phosphoprotein with a molecular mass of 26 kDa has received considerable attention. This protein has been implicated as playing a major role in exocytosis based on studies indicating that the protein is a specific substrate of protein kinase A and that the amino acid acceptor for phosphorylation is serine (Quissell et al, 1992) . Reports by Takuma suggest that protein kinase A activation (Takuma and Ichida, 1988) and protein kinase A-dependent protein phosphorylation (Takuma, 1988) may not be directly involved in the regulation of parotid gland exocytosis. This is based on observations that inhibition of cAMP-dependent protein kinase A markedly reduced phosphorylation of 21-and 26-kDa proteins without affecting amylase release. However, permeabilized rat parotid acinar cells, when incubated with a combination of site-selective cAMP analogs, resulted in a synergistic stimulation of amylase release. Through these studies, Takuma (1990) 
Following stimulation with isoproterenol, an increase in phosphorylation of two major proteins, Mr 60 kDa and 72 kDa, associated with secretory granule membrane has also been observed recently by Marino et al (1990) . The increased phosphorylation of these phosphoproteins correlated well with the release of amylase (6-fold higher) following isoproterenol treatment as opposed to the propranolol-treated control. It appears that there exists a common integral membrane protein, with similar electrophoretic mobilities, in granular membranes of both the parotid gland and exocrine pancreas. Even though the relationship of the phosphorylation levels of these proteins to pancreatic secretion is yet to be characterized, it may be hypothesized that the secretory granule membrane could form a potential site of phosphorylation related to secretion.
Protein phosphorylation is characterized by two processes: one involving the addition of phosphate and the other involving the removal of phosphate from the protein. These processes are catalyzed by two enzymes, protein kinases and protein phosphatases, respectively. In eukaryotic organisms, these two enzymes are categorized based upon substrate specificity. Protein kinases are classified into two groups, serine and threonine kinases and the tyrosine kinases. Although phosphatases mediate various biological catalyses, these proteins can be differentiated into non-specific phosphatases, serine and threonine phosphoprotein phosphatases, and protein-tyrosine phosphatases.
The majority of modifications is known to occur on serine and threonine residues in the control of various cellular functions. However, with the identification of tyrosine kinases associated with several viral oncogenes and growth factor receptors, it has become clear that tyrosine phosphorylation is an important regulator of various physiological processes. The significance of tyrosine dephosphorylation was not discovered until 1988, when the amino acid sequence of a phosphatase with no similarity to known serine and threonine phosphatases was identified (Tonks et al, 1988) . Protein tyrosine phosphatases have been shown to be involved in signal transduction pathways associated with the G protein-coupled family of receptors (Fischer et al, 1991) . 
PHOSPHATASES
Protein phosphatases were originally thought of as enzymes that simply reversed the action of kinases. However, with the identification of active and inactive forms of enzyme, phosphatases are now considered as not merely a switch-off but a dynamic process that plays a central and significant role in cellular physiology. The pro-6(2):119-131 (1995) tein tyrosine phosphatases are subcategorized into three groups: (1) receptor-like protein tyrosine phosphatases, (2) intracellular protein tyrosine phosphatases, and (3) dual-specificity protein tyrosine phosphatases (Stone and Dixon, 1994; Kwakand Dixon, 1995) . The receptor-like protein tyrosine phosphatases act as cell adhesion molecules (Susann et al, 1993) . The intracellular protein tyrosine phosphatases contain a single catalytic domain and various amino and carboxy terminal extensions. Studies conducted on baby hamster kidney cells with RCM-lysozyme used as substrate indicate that the COOH terminal of the phosphatases is critical for localization and regulation of enzyme activity (Fischer et al, 1991) .
Another factor that contributes to the regulation of phosphatases is the availability of substrates. The physiological substrates for tyrosine phosphatases are rare, although observations suggest some potential candidates. Commonly used 'artificial' substrates in in vitro reactions are the P subunit of insulin or insulin-like growth factor 1 . Tyrosine phosphorylated casein, RCM-lysozyme, myelin basic protein, and synthetic peptide such as tyrosine phosphorylated raytide, angiotensin, and src peptide are also used as model substrates. In view of the lack of natural substrates, it may be difficult to extend the results of in vitro reactions obtained with the above substrates to in vivo conditions. Further, there is no evidence for the existence of a 'one kinase-one phosphatase' relationship. Different effectors such as divalent cations, polyamines, protein activators, and inhibitors might also exhibit various sensitivities to different phosphatases.
(C) TYROSINE PHOSPHORYLATION IN THE
MEDIATION OF SECRETION
The protein tyrosine phosphatases are known to regulate cell growth and proliferation, cell cycle, and cytoskeletal integrity in response to a variety of external stimuli (Stone and Dixon, 1994) . Their role as tumor suppressors, T-cell activators, and in bacterial pathogenesis has been well-documented (Gould and Nurse, 1989; Pingel and Thomas, 1989; Guan and Dixon, 1994; Hannon et al, 1994) . The literature on protein phosphorylations and its regulation, especially by phosphatases, in secretion is very limited.
In permeabilized mast cells, it has been shown that the presence of ATP delays the onset of secretion and the delay may be reduced by increasing concentrations of Ca 2+ and GTP (Howell et al, 1987; Gomperts, 1990) . These observations lead to the hypothesis that exocytosis involves protein dephosphorylation. Subsequently, using a truncated recombinant form of rat brain protein tyrosine phosphatases, Jena et al. (1991) have shown that exogenous addition of protein tyrosine phosphatase stimulated Ca 2+ -dependent amylase release in pancreatic acinar cells. The increase in Ca 2+ -dependent amylase release following addition of protein tyrosine phosphatase was also found to be time-dependent. Sodium fluoride, an inhibitor of phosphatase activity, induced amylase release in parotid acini which was dependent on extracellular Ca 2+ concentrations and accumulation of inositol phosphate intermediates (Tojyo etal, 1991) . The sodium-fluoride-induced amylase release was shown to be mediated by the breakdown of phosphoinositides, thereby leading to calcium mobilization. However, fluoride may also act on GTP-binding proteins coupled to phospholipase C. These conflicting studies suggest a further need to elucidate the true involvement of phosphatases in regulation of parotid gland exocytosis.
Similar to pancreatic acinar cells, there exists a relationship between the protein tyrosine phosphatases and amylase exocytosis in parotid acinar cells. Incubation of parotid acinar cells with sodium orthovanadate not only prevented an increase in phosphatase activity measured by pNPP hydrolysis but also inhibited the amylase release that is stimulated by P-adrenergic agonist (Purushotham et al, 1995a) . There are at least four proteins-identified with Mr 40, 45, 70, and 95 kDa-that undergo increased phosphorylations on tyrosine residues upon stimulation by orthovanadate.
An attempt has been made to elucidate the subcellular localization of protein tyrosine phosphatases in parotid acinar cells. The level of secretory granule membrane-associated protein tyrosine phosphatase, namely, Syp, was found to be twice that of a cytoplasmic fraction (Purushotham et al, 1995b) . Further, the secretory granule-associated protein tyrosine phosphatase possesses the ability to dephosphorylate tyrosine-phosphorylated myelin basic protein to a significantly higher degree than the protein tyrosine phosphatases associated with cytoplasm, total membrane, plasma membrane, and total lysate fractions (Purushotham et al, 1995b) . The parotid gland protein tyrosine phosphatases appear to be consistent with pancreatic protein tyrosine phosphatases, in that the specific activities of the granule membraneassociated protein tyrosine phosphatase are higher than in other subcellular fractions (Jena etal, 1991) . The Ca 2+ -dependent release of amylase stimulated by recombinant protein tyrosine phosphatase, the inhibition of phosphatase activity and release of amylase in the presence of sodium orthovanadate (a PTPase inhibitor), and the association of protein tyrosine phosphatase with the secretory granules-all suggest the potential involvement of tyrosine phosphorylations in regulated secretion {jenaetal, 1991; Purushotham et al, 1995b) .
(V) Summary/Future Directions
At this time, our basic understanding of cell proliferation in the salivary gland mirrors that observed for neoplastic and transformed cells in general. The network of events that follows binding of a growth factor to its receptor and activation of cytoplasmic kinase activity has been the focus of intense investigation. Although much has been learned about the post-receptor mechanism of phosphotyrosine second messenger signaling, large information gaps still exist. What has been learned indicates that growth factor receptor kinases phosphorylate many proteins, including cytoskeletal components, tumor suppressor proteins, oncogenes, and key components of other second messenger signaling systems. Thus, stimulation of the phosphotyrosine pathway appears to influence most of the cellular systems that regulate mitosis and differentiation.
In the salivary glands, chronic isoproterenol treatment and, to a lesser degree, dietary modulation and neural innervation have been used as models to detail mechanisms relating not only to secretory function but also to the principles regulating proliferation in a fullydeveloped and -differentiated tissue. The cascade of protein interactions involving the phosphotyrosine signaling pathway following p-agonist administration has been detailed to a high degree from the plasma membrane through the cytoplasm (Cantley et al, 1991) . The detection of activated MAP-kinase within the nuclei of isoproterenol-treated acinar cells allows us to speculate on the route of activation of transcription factors as well as the cyclins and cyclin-dependent kinases that drive DNA synthesis and cell mitosis. Clear differences must exist between the uncontrolled growth of salivary gland tumors and the self-limiting proliferative response we observe in the chronic isoproterenol, dietary changes, and neural stimulation models of salivary gland hypertrophy and hyperplasia.
The control of cell growth is a delicate balance between negative and positive regulatory factors. The evidence for these negative regulatory factors, which have been termed tumor suppressor and apoptotic genes, has largely been determined through studies in which their normal growth-suppressing function has been disrupted. Cell hybrid experiments, familial cancer patterns, and loss of heterozygocity lead to the suggestion that neoplastic growth can arise by recessive genetic alterations or mutations (MacKayetfl!., 1992) . This is in contrast to the dominant transformation of cells involving mutations of the phosphotyrosine signaling pathway. Current research shows that loss of heterozygocity is most common in the mutations of the p53 gene (Holstein et al, 1991) . The p53 gene product, which is similar to the Rf? 110 gene product, acts to suppress growth through its action as a transcription factor which can suppress growth in the hypophosphorylated state. Thus, the observation of hyperphosphorylation of Rb 110 in proliferating acinar cells (Lee et al, 1992) suggests a role for these genes in normal and abnormal growth control of the salivary glands.
The observation of carbohydrate alterations on glycoproteins of proliferating acinar cells provides a mechanism by which cell surface galactosyltransferase can activate the phosphotyrosine signal transduction pathway leading to growth following isoproterenol treatment . One of the hallmarks of transformed cells is the alteration of carbohydrate moieties of cell surface glycoproteins. These changes often lead to the re-expression of developmentally expressed carbohydrate antigens. In several cancer cell lines, surface galactosyltransferase appears to regulate proliferation. Thus, it is often noted in abnormal growth that "oncogenesis recapitulates ontogeny". The alteration in carbohydrate structures of the EGF-R may yield a similar scenario, where the substrate for galactosyltransferase is the re-expression of fetal carbohydrate moieties or cell surface receptors which may be involved in various tissue development in utero.
With the activation of cytoplasmic tyrosine kinases and tyrosine phosphatases, one is left with the question of how this may effect differentiated salivary gland function. The chronic activation of the phosphotyrosine second messenger pathway observed in human salivary neoplasms does appear to affect the transcription rate and subsequent presence of amylase activity in tumor cell lysates (Morley and Hodes, 1988 ). Short-term growth induced by EGF increases transcription and release of amylase from the gland into saliva (Purushotham et al, 1995a ), but we do not know the consequence to gland function during chronic activation as in neoplasms.
Using transgenic animals with oncogenic forms of components of the phosphotyrosine pathway (Cantley et al, 1991) , we may be able to evaluate the long-term effects of abnormal growth of the salivary gland on differentiated function. Obviously, a complete understanding of the role of the individual proteins involved in regulating salivary gland cellular proliferation and differentiated function is necessary before we contemplate the use of molecular strategies which may activate a salivary progenitor or stem-type cell to re-populate the gland following its destruction by disease or cancer therapy, such as occurs as a consequence of radiation. Thus, our ability to manipulate the cell machinery to restore gland function requires further understanding of the controls which regulate the delicate balance between controlled differentiated function and neoplastic behavior.
